KLBF Catat Kenaikan Laba Bersih 18,42% YoY di Semester I-2024

IDXchannel

PT Kalbe Farma Tbk (KLBF) mencatat kinerja positif, selama 6 bulan pertama di 2024. Pendapatan dan laba bersih perseroan kompak naik, di periode januari hingga Juni 2024.

Transcript

00:00Thank you, Mr. Mayor, for being with us in the Market Bus segment at the beginning of this month, Mr. Mayor.

00:05We will present information about the latest financial reports.

00:09We start from PTKLB Pharma Tbk or KLBF, noting positive performance for the first 6 months in 2024.

00:16The income and net profit of the company increased in the period from January to June 2024.

00:21According to the information released by the Indonesian Stock Exchange, PTKLB Pharma Tbk or KLBF,

00:31the net profit in the first month of 2024 was Rp1.80 trillion.

00:37The figure increased by 18.42% compared to the same period in 2023 at Rp1.52 trillion.

00:47The increase in net profit was pushed from the growth of 7.58% year-on-year income to Rp16.32 trillion.

00:56Previously, KLBF recorded an income in the first semester of 2023 of only Rp15.17 trillion.

01:04KLBF's income is dominated by domestic income of Rp15.50 trillion,

01:10Rp4.14 trillion in medicine receipts, Rp1.98 trillion in health products,

01:18Rp4.03 trillion in nutrition, and Rp5.34 trillion in distribution and logistics.

01:25Meanwhile, the income from exports contributed Rp823.15 billion.

01:32In addition, KLBF's share price increased by 9.55% year-on-year,

01:37to Rp9.86 trillion from the same period in the previous year at Rp9 trillion.

01:44Then KLBF's total assets also increased by 5.58%,

01:49to Rp28.56 trillion compared to the end of 2023.

01:55Total liabilities and total equities also increased to Rp5.02 trillion and Rp23.53 trillion.

Category

Transcript

Be the first to comment

Recommended